CohBar Resumes CB4211 Phase 1b Clinical Trial

Print Friendly, PDF & Email

TREATMENT FOR LIVER DISEASE: MENLO PARK, Calif., July 07, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that it has resumed the Phase 1b stage of its Phase 1a/1b clinical trial of CB4211, its […]